Primo Nutraceuticals Inc.
BUGVF
OTC PK
| 04/30/2020 | 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 188.70K | 36.70K | 380.50K | 512.20K | 83.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 188.70K | 36.70K | 380.50K | 512.20K | 83.50K |
| Operating Income | -188.70K | -36.70K | -380.50K | -512.20K | -83.50K |
| Income Before Tax | -190.50K | -64.50K | -385.70K | -3.28M | -108.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -190.50K | -64.50K | -385.70K | -3.28M | -108.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -190.50K | -64.50K | -385.70K | -3.28M | -108.60K |
| EBIT | -188.70K | -36.70K | -380.50K | -512.20K | -83.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.01 | -0.06 | -0.65 | -0.03 |
| Normalized Basic EPS | -0.01 | 0.00 | -0.04 | -0.06 | -0.02 |
| EPS Diluted | -0.02 | -0.01 | -0.06 | -0.65 | -0.03 |
| Normalized Diluted EPS | -0.01 | 0.00 | -0.04 | -0.06 | -0.02 |
| Average Basic Shares Outstanding | 9.44M | 9.23M | 6.61M | 5.08M | 4.18M |
| Average Diluted Shares Outstanding | 9.44M | 9.23M | 6.61M | 5.08M | 4.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
